Forward Pharma to Present at the 7th Annual Leerink Partners Global Healthcare Conference
February 07 2018 - 7:30AM
Forward Pharma A/S (NASDAQ:FWP) (the “Company”) today announced
that Dr. Claus Bo Svendsen, the Company’s Chief Executive Officer,
will give a corporate update at the 7th Annual Leerink Partners
Global Healthcare Conference in New York, NY. Dr. Svendsen will
present on Thursday, February 15, 2018 at 10:30 AM ET and host
one-on-one meetings.
Investors and other interested parties may access a live audio
webcast of our conference presentation by visiting the investor
page on the Company’s website (www.forward-pharma.com). The
audio replay will be available via our website for 90 days
following the presentation.
About Forward
Pharma: Forward Pharma A/S is a Danish biopharmaceutical
company that commenced development in 2005 of FP187, a proprietary
formulation of DMF for the treatment of inflammatory and
neurological indications. The Company granted to Biogen an
irrevocable license to all of its IP through the recent Settlement
and License Agreement and received from Biogen a non-refundable
cash fee of $1.25 billion in February 2017, with the return of EUR
917.7 million to shareholders through a capital reduction in
September 2017. The Company has the opportunity to receive
royalties from Biogen on sales of Tecfidera® or other DMF products
for MS, dependent on, among other things, successfully appealing
the U.S. interference and a favorable outcome in Europe with
respect to the EP2801355 Opposition Proceedings, including any
appeal thereto.
The principal executive offices are located at Østergade 24A,
1st Floor, 1100 Copenhagen K, Denmark and our
American Depositary Shares are publicly traded on NASDAQ Stock
Market (FWP). For more information about the Company,
please visit our website at http://www.forward-pharma.com.
Forward Pharma A/S Investor Relations
Contact:Forward Pharma A/SDr. Claus Bo Svendsen, Chief
Executive OfficerInvestor Relationsinvestors@forward-pharma.com
The Trout Group John Grazianojgraziano@troutgroup.com+1 (646)
378 2942
Forward Pharma AS (NASDAQ:FWP)
Historical Stock Chart
From Aug 2024 to Sep 2024
Forward Pharma AS (NASDAQ:FWP)
Historical Stock Chart
From Sep 2023 to Sep 2024